On Tuesday, Pfizer (NYSE: PFE) stepped into the earnings spotlight, announcing a higher third-quarter profit compared to last year. The pharmaceutical firm earned 43 cents per share, or 51 cents per share in adjusted earnings. A year ago, PFE earned 34 cents per share before item exclusions. The Street expected PFE to report third-quarter earnings of 48 cents per share excluding items. Quarterly revenue checked in at $11.62 billion, 3% lower than last year's third-quarter revenue. Revenue was pulled roughly 5% lower due to unfavorable foreign exchange rates.

First, who are the Nobel Prize winners? Why is their research so important in the areas of aging and cancer detection?
Iran's flawed democracy is still better than most of the political systems among other countries in the region. For the past few decades the morality police, prodded by religious literalism, have mandated women to cover themselves when they are out in public. This same religious literalism has impeded the potential of a country that has a large population, in a key geographic region, with oil and other natural resources.
This morning, 

